Literature DB >> 34866831

Healthcare-associated Infections in Pediatric Patients in Neurotrauma Intensive Care Unit: A Retrospective Analysis.

Chandrakant Prasad1, Ashish Bindra1, Parul Singh2, Gyaninder P Singh1, Pankaj K Singh3, Purva Mathur4.   

Abstract

BACKGROUND: Healthcare-associated infections (HAIs) can impact the outcome following traumatic brain injury (TBI) in children. We undertook a retrospective observational study to see the incidence, risk factors, and microbiological profile for HAIs in pediatric TBI. We also studied the impact of baseline patient characteristics, HAIs on patient outcome, and antibiotic resistance of different types of bacteria.
MATERIALS AND METHODS: Data on pediatric TBI patients of age up to 12 years were collected via a computerized patient record system (CPRS) from January 2012 to December 2018. Descriptive Chi-square test and Wilcoxon signed rank test were used to characterize baseline parameters. General linear regression models were run to find an unadjusted and adjusted odds ratio (OR).
RESULTS: HAIs were found in 144 (34%) out of 423 patients. The most commonly seen infections were of the respiratory tract in 73 (17.26%) subjects. The most predominant microorganism isolated was Acinetobacter baumannii in 188 (41%) samples. A. baumannii was sensitive to colistin in 91 (48.4%) patients. Male gender (OR 0.630; p-value 0.035), fall from height (OR 0.374; p-value 0.008), and higher injury severity scale (ISS) (OR 1.040; p-value 0.002) were independent risk factors for development of HAIs. Severe TBI, higher ISS and Marshall grade, and HAIs were significantly associated with poor patient outcome.
CONCLUSION: Severe TBI poses a significant risk of HAIs. The most common site was the respiratory tract, predominately infected with A. baumannii. HAIs in pediatric TBI patients resulted in poor patient outcome. HOW TO CITE THIS ARTICLE: Prasad C, Bindra A, Singh P, Singh GP, Singh PK, Mathur P. Healthcare-associated Infections in Pediatric Patients in Neurotrauma Intensive Care Unit: A Retrospective Analysis. Indian J Crit Care Med 2021;25(11):1308-1313.
Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd.

Entities:  

Keywords:  Healthcare-associated infection; Pediatric; Trauma; Traumatic brain injury

Year:  2021        PMID: 34866831      PMCID: PMC8608634          DOI: 10.5005/jp-journals-10071-24012

Source DB:  PubMed          Journal:  Indian J Crit Care Med        ISSN: 0972-5229


HIGHLIGHTS

Along with neurological morbidity, pediatric traumatic brain injury poses a significant risk of HAIs. Higher injury severity score, male gender, and fall from height were associated with a significant risk of infections. Respiratory tract infections are the most common in these patients. Severe injuries with HAIs resulted in poor outcome.

INTRODUCTION

Traumatic brain injury (TBI) is one of the leading causes of morbidity and mortality in children both in the developing and developed world.[1] Along with neurological morbidity, neurotrauma poses a significant risk of infections. Improvement in outcome from TBI can be hampered by the development of healthcare-associated infections (HAIs). The reported incidence rate is as high as 50% and mortality as high as 37%.[2] Among critically ill, pediatric trauma patients are at the highest risk of the development of HAIs.[3] Transient immunosuppression or immunoparalysis associated with neurological insults secondary to cytokine release and brainstem irritation induced activation of the hypothalamus–pituitary–adrenocortical axis contribute to HAIs in TBI.[4] HAIs can also lead to multiple organ dysfunction along with worsening secondary brain injury.[5] Results of adequate effort to manage such critically ill children can be optimized by knowing epidemiological data and understanding of risk factors for the development of HAIs. We, therefore, undertook a retrospective, observational study to see the HAI on rate in pediatric patients admitted to neurotrauma intensive care units over a period of 7 years. We analyzed the microbiological samples of all the pediatric TBI patients with suspicion of HAIs submitted for culture and antimicrobial susceptibility testing. We also studied risk factors for HAIs and the impact of baseline characteristics, HAI on outcome, and antibiotic resistance in different types of bacteria isolated in these patients.

MATERIALS AND METHODS

After taking approval from the institutional ethics committee (IEC-887/04.09.2020), we did a retrospective analysis of pediatric trauma patients admitted at level 1 trauma center. We analyzed microbiological samples of pediatric TBI patients from January 2012 to December 2018, which were submitted to the microbiology laboratory for testing. All the positive culture isolates were identified up to the species level by the Vitek 2 GN card (version 8.1, Inc., Durham, United States of America). Antimicrobial susceptibility testing was performed by Kirby–Bauer disc diffusion method on Mueller Hinton agar and by Vitek 2 system. The results of antibiotic susceptibility were interpreted based on the Clinical and Laboratory Standards Institution guidelines. Clinical characteristics and admission variables were collected via the computerized patient record system (CPRS) database. CPRS (version 1.0.26.76), supported by Edgeware Technologies India PVT limited, was used. Data of all the trauma patients were entered and updated in this system by all the concerned clinical and technical staff. We used predecided proforma to retrieve the data of patients who met inclusion and exclusion criteria. All the data were entered into an excel worksheet for final analysis. Patients up to 12 years of age, of either gender, with TBI admitted to neurotrauma intensive care unit were included. Children who were brought dead or had signs of infection at the time of admission or up to 48 hours after admission were excluded from the study. Patients with a length of hospital stay less than 48 hours were excluded. We retrieved data of culture and sensitivity results along with details of corresponding samples. Data of 423 patients were included for analysis after screening for inclusion and exclusion criteria. Data collected included patient demographics (age, gender), admission Glasgow coma score (GCS), mechanism of injury, computed tomography (CT) findings at admission, Marshall grading, injury severity score, details of invasive devices, microbiological infections, antimicrobial sensitivity, the outcome in terms of length of hospital stay, GCS at discharge, and mortality. Patients were classified into two groups: group A (with HAIs) and group B (without HAIs). For descriptive purposes, microorganisms were divided into Gram-negative bacilli (GNB), Gram-positive cocci (GPC), and fungi. For all analysis purposes, patients were further subclassified into age-groups 0–2 years, 2–4 years, and 4–12 years. TBI was divided into mild, moderate, and severe head injuries based on admission GCS (13–15 mild, 9–12 moderate, and 3–8 severe). The injury type was described as either polytrauma or isolated TBI. Mechanism of injury was categorized into fall from a height, road traffic accident (RTA), penetrating injuries, and others (suffocation, drowning, and poisoning). Marshall grading was done based on findings of admission CT scan.[6] The injury severity scale (ISS) calculation was based on the highest abbreviated injury scale (AIS) code of the three most injured body regions.[7] All the different types of samples like respiratory samples [broncho-alveolar lavage (BAL), tracheal aspirate, endotracheal tubes], blood, urine, cerebrospinal fluid (CSF), bone/tissue, and invasive devices were analyzed. Invasive devices included intracranial pressure (ICP) monitoring catheters, external ventricular drains (EVD), and intercostal drains (ICD). The outcome was calculated based on the length of hospital stay and neurological status at discharge. Latter was classified into mild, moderate, and severe categories based on GCS at discharge along with class 4 given to dead patients. Duration of hospital stay was calculated in days.

Statistical Methods

Descriptive statistical methods were used to analyze intragroup characteristics. Intergroup baseline characteristics were compared using Chi-square tests for categorical variables and Wilcoxon signed rank test for continuous nonparametric variables. Incidence of all infections and antibiotic sensitivity were calculated using descriptive analysis cross-tab model. The unadjusted and adjusted odds ratios (OR) of risk factors for different HAIs and mortality were derived using univariate and multiple logistic regression analyses, respectively. Models were run first without adjustment for confounding variables to find potential risk factors. The final multiple regression model was run based on the level of significance (p-value<0.05) seen in the unadjusted logistic regression model to find confounder adjusted risk factors for infections and mortality. The impact of infections and binary baseline characteristics on the outcome (hospital stay and discharge status) was analyzed using the Mann–Whitney U test. Spearman's rho and Pearson's correlation coefficient were derived to find out the relation between categorical and continuous baseline characteristics of patient outcome, respectively. Chi-square tests were run to find the association between mortality and all categorical variables. Statistical analysis was performed using the SPSS for Windows 25 (SPSS, Chicago, Illinois, United States). A p-value of less than 0.05 was considered statistically significant.

RESULTS

Microbiological samples for 423 pediatric TBI patients were analyzed. Demographic data and baseline characteristics of patients are described in Table 1. A total of 232 (54.8%) children had severe TBI. The majority of the patients, 395 (93.4%), had isolated TBI. The most common mechanism of injury was fall from height in 274 (64.8%) patients. The baseline variables were comparable across the groups except for gender, mechanism of injury, and ISS. Group A patients had significantly higher ISS value (p-value 0.003) as shown in Table 1.
Table 1

Demographic profile and baseline characteristics of patients

  Intergroup
Variable Intragroup (N = 423) Group A (N = 144) Group B (N = 279) p value
Age (mean, SD)5.44 (3.41)5.63 (3.31)5.33 (3.46)0.269
Age distribution (n, %) 
0–2 years106 (25.1)34 (23.6)72 (25.8)0.307
2–4 years97 (22.9)28 (19.4)69 (24.7) 
4–12 years220 (52.0)82 (56.9)138 (49.5) 
Sex (M:F) 279:144 85:59 194:850.031
Admission GCS (median, IQR)7 (3–15)7 (3–15)8 (3–15)0.181
Admission status (n, %) 
Mild (GCS 13–15)123 (29.1)40 (27.8)83 (29.7)0.532
Moderate (GCS 9–12)68 (16.1)20 (13.9)48 (17.2) 
Severe (GCS 3–8)232 (54.8)84 (58.3)148 (53.0) 
Type of injury (n, %) 
Polytrauma28 (6.6)12 (8.3)16 (5.7)0.308
Isolated TBI395 (93.4)132 (91.7)263 (94.3) 
Mechanism of injury (n, %) 
Fall from height274 (64.8)80 (55.6)194 (69.5)0.032
Road traffic accident104 (24.6)44 (30.6)60 (21.5) 
Penetrating injury9 (2.1)3 (2.1)6 (2.2) 
Others36 (8.5)17 (11.8)19 (6.8) 
Marshall grade (n, %) 
Grade 178 (11.3)17 (11.8)31 (11.1) 
Grade 2270 (63.8)85 (59.0)185 (66.3)0.565
Grade 322 (5.2)11 (7.6)11 (3.9) 
Grade 415 (3.5)5 (3.5)10 (3.60) 
Grade 565 (15.4)25 (17.4)40 (14.3) 
Grade 63 (0.7)2 (0.7)1 (0.7) 
Injury severity scale (mean, SD)11 (8.29)12.70 (8.20)10.13 (8.16)0.003
Invasive devices (ICP sensor, EVD, ICD) (n, %)90 (21.3)36 (25.0)54 (19.4)0.179

GCS, Glasgow Coma Scale; ICP, intracranial pressure; EVD, external ventricular drain; ICD, intercostal drain

Demographic profile and baseline characteristics of patients GCS, Glasgow Coma Scale; ICP, intracranial pressure; EVD, external ventricular drain; ICD, intercostal drain A total of 2,781 samples of 423 patients were received for culture, out of which 454 (16.3%) samples turned positive in 144 (34%) patients. Maximum infections were found in respiratory samples, 73 (17.3%) patients followed by blood in 45 (10.6%). Next in sequence were wound 39 (9.2%), CSF 21 (4.9%), urine 18 (4.3%), bone/tissue 12 (2.8%), and invasive device 4 (0.9%) (Table 2). GNB grown in cultures of 351 (12.6%) isolates while GPC in 103 (3.2%) (Supplementary Table 1).
Table 2

Incidence of infections in studied patient population

  Number of patients Percentage
Any healthcare-associated infection14434.04
Blood infections4510.64
Wound infections399.22
Respiratory infections7317.26
CSF infections214.96
Urine infections184.26
Invasive device infections122.84
Bone/tissue infections40.95

CSF, cerebrospinal fluid

Incidence of infections in studied patient population CSF, cerebrospinal fluid Acinetobacter baumannii was the most commonly isolated [188 (41%)] microorganisms in blood, respiratory tract, 92 (60%); CSF, 45 (52%); and invasive device, 5 (31%). Staphylococcus aureus was the most common microorganism isolated in wound 39 (45.4%) and bone/tissues 3 (75%). Escherichia coli grew commonly in urine 9 (30%) (Supplementary Table 2). GNB and GPC bacteria were classified separately as per their sensitivity to antibiotics. A. baumannii was found to be sensitive to colistin in 91 (48.4%) cases followed by tigecycline in 65 (34.5%) and netilmicin in 26 (13.83%). It was resistant to all remaining antibiotics. S. aureus was sensitive to linezolid in 74 (91.4%), teicoplanin in 73 (90.1%), and vancomycin in 73 (90.1%). Colistin in 30 (78.9%), tigecycline in 24 (63.2%), amikacin in 22 (57.9%), and meropenem in 19 (50%) were found effective against E. coli (Supplementary Tables 3 and 4). Risk factors for HAIs overall and specific for different infection sites GCS, Glasgow Coma Scale Impact of baseline characteristics on outcome GCS, Glasgow Coma Scale; TBI, traumatic brain injury Potential and independent risk factors for HAIs were derived using univariate and multiple logistic regression analysis, respectively. Sample-wise specific risk factors for different HAIs were also listed (Table 3). Male gender, fall from height, and higher ISS were found as potential as well as independent risk factors for HAIs (OR 0.630; p-value 0.035,OR 0.374; p-value 0.008, and OR 1.040; p-value 0.002, respectively) Severe TBI (OR 0.371; p-value 0.018) and higher ISS (OR 1.061; p-value <0.001) turned as independent predictors for respiratory tract infection while male gender was found as risk factor (OR 0.216; p-value 0.004) for urinary tract infections. Confounder adjusted risk factors for CSF infection were higher ISS (OR 0.937; p-value 0.019). Severe TBI (OR 2.416; p-value 0.022) and fall from height (OR 0.248; p-value 0.003) came out as independent risk factors for wound infections while lower age-group (0–2 years) was a risk factor for device-related infections (OR 9.140; p-value 0.004).
Table 3

Risk factors for HAIs overall and specific for different infection sites

  Odds of infection Adjusted odds of infection
Variable OR p value OR (lower CI, upper CI) p value
Age distribution 
0–2 years0.7950.359  
2–4 years0.6830.148  
Male sex0.6310.0310.630 (0.410, 0.967)0.035
Admission GCS 
Mild0.8490.488 
Moderate0.7340.302  
Polytrauma1.4940.311  
Mechanism of injury 
Fall from height0.4610.0310.374 (0.171, 0.774)0.008
Road traffic accident0.8200.609 
Penetrating injury0.5590.457 
Marshal Grading1.0770.359  
Injury severity scale1.0370.0031.040 (1.015, 1.066)0.002
Any invasive device0.7200.180  
BloodNo significant risk factor found
Respiratory tract 
Male sex0.6030.0540.640 (0.375, 1.094)0.103
Severe head injury0.229<0.0010.371 (0.163, 0.844)0.018
Injury severity scale1.075<0.0011.061 (1.028, 1.095)<0.001
Urine 
Male sex0.2420.0050.216 (0.076, 0.612)0.004
CSF 
Injury severity scale1.0560.0190.937 (0.888, 989)0.019
Wound 
Severe head injury3.3920.0012.416 (1.134, 5.151)0.022
Fall from height0.183<0.0010.248 (0.100, 0.616)0.003
Road traffic accident0.2460.0060.436 (0.150, 1.266)0.127
Any invasive device5.5000.0214.005 (9.12, 17.589)0.066
Device 
0–2 years age group5.9050.0109.140 (2.043, 40.898)0.004
Bone/tissueNo significant risk factor found

GCS, Glasgow Coma Scale

The outcome was analyzed in terms of length of hospital stay 12 (2–1,289) days, discharge GCS 13 (3–15), and mortality in 29 (6.9%) patients (Table 4). Severe TBI and higher ISS (p-value <0.001 for both) significantly prolonged hospital stay, while the same factors along with advanced Marshall grade were found as significant predictors for poor GCS at discharge (p-value <0.001 for all) and mortality (p-value 0.020, <0.001 and <0.001, respectively).
Table 4

Impact of baseline characteristics on outcome

  Prolonged hospital stay Poor discharge status (GCS) Mortality
Variable Mean rank p value Mean rank p value Chi-square value p value
Type of Injury 0.347 0.0082.207 
Polytrauma191.00 159.13 (n = 0)0.137
Isolated TBI213.49 215.75 (n = 29) 
  r value p value r value p value Chi-square value p value
Admission GCS0.306<0.0010.449<0.0017.8020.020
Mechanism of injury0.0360.4590.0490.3193.7070.295
Marshall grading0.0890.0680.180<0.00124.773<0.001
Injury severity scale0.191<0.0010.701<0.00185.10<0.001

GCS, Glasgow Coma Scale; TBI, traumatic brain injury

HAIs were found to prolong the hospital stay (p-value <0.001) and predict poor GCS at discharge (p-value 0.003) (Table 5). Among HAIs, blood infections (p-value 0.021), respiratory infections (p-value <0.001), urinary infections (p-value 0.001), and device-related infections (p-value 0.032) were found to significantly increase the duration of hospital stay. Poor discharge GCS was associated with respiratory infections (p-value <0.001) and device-related infections (p-value 0.001). CSF infections (p-value 0.013) were found to be significantly associated with patient mortality (Supplementary Table 5).
Table 5

Comparison of effect of HAIs on outcome in both the groups

  Prolonged hospital stay Poor discharge status Mortality
Infection sites Group A (mean rank) Group B (mean rank) p value Group A (mean rank) Group B (mean rank) p value Chi-square value p value
Any infection248.50193.16<0.001234.40200.440.0030.7460.388
Blood251.72207.270.021231.08209.730.2160.3260.568
Respiratory261.16201.75<0.001263.35201.29<0.0011.0320.310
Urine304.64207.880.001244.44210.560.1990.0500.823
CSF239.55210.560.289254.02209.800.0719.9460.002
Wound229.44210.230.350196.35213.590.3494.8940.027
Device286.50209.320.032295.25209.570.0011.8720.172
Bone/tissue180.63212.300.606190.00212.210.7012.0820.149

GCS, Glasgow Coma Scale

Comparison of effect of HAIs on outcome in both the groups GCS, Glasgow Coma Scale

DISCUSSION

Along with other ailments, neurotrauma is a constant threat to the health of children both in the developed and developing world. HAIs in pediatric TBI patients pose a special challenge while managing pediatric TBI patients. Such infections can have a significant impact on the length of hospital stay, patient outcome, and healthcare costs.[8] Infection rate, microorganisms type, and antimicrobial susceptibility pattern may vary across the globe. Keeping these facts in mind, we planned this retrospective study to see HAIs profile and associated risk factors to address challenges during care and prognostication of pediatric TBI patients. We found a 34% incidence of HAIs in pediatric TBI patients admitted to neurotrauma intensive care units. Data from West report a 13.3–50% incidence of HAIs in pediatric polytrauma patients.[2,9] A study by Osborn and colleagues reports a 2% incidence of sepsis among 30,303 trauma patients across all age-groups.[10] Sbrinick et al. reported a 13% incidence of infection in pediatric polytrauma with TBI.[9] However, we found higher incidence HAIs in predominately TBI patients. The incidence of infection is more in trauma care units as compared to other critically ill patients. We witnessed a high incidence of respiratory tract infections (17%), which is higher as compared to data reported from Western countries.[11] The incidence of bloodstream infections varies across different pediatric intensive care units around the globe. Incidence of bloodstream infection was reported up to 30% in the pediatric intensive care unit in north India earlier; however, an incidence as low as 0.06% has been reported in critically ill pediatric patients without trauma.[12,13] Our data suggest around 11% incidence of bloodstream infections in pediatric TBI patients. Urinary tract and invasive device-related infections were less as compared to available data from Western countries.[14,15] A. baumannii was the most common (41%) overall isolate in our study. Klebsiella pneumoniae (24%) and S. aureus (18%) were isolated earlier as the most common microorganisms in blood in other pediatric intensive care units from developing countries;[12] however, we found A. baumannii (21%) and K. pneumoniae (19%) to be more prevalent in pediatric TBI patients. S. aureus in our study were reported in only 6% of blood infections. A. baumannii was also the most common colonizer in the respiratory tract, CSF, and invasive device, which was in contrast to that reported from Western countries where S. aureus is the most common pathogen.[14-16] A. baumannii was also found to be multidrug resistant in more than half of the patient population. It was found susceptible to colistin in 48.4% and tigecycline in 34.5% of patients. So, the largest portion of difficult-to-treat microbiota is shared by A. baumannii in our setup. Up to 77% susceptibility of A. baumannii was reported in a study in Kenya.[17] Carbapenem resistance has been reported in 4.25–16% of K. pneumoniae to carbapenem in recent years.[18] Our findings also suggest an alarming 40–50% carbapenem resistance for K. pneumoniae. The sensitivity pattern of S. aureus was derived as linezolid (91%), teicoplanin (90%), and vancomycin (90%), similar to that described in Western countries as linezolid (97%), teicoplanin (97%), and vancomycin (95%).[19] In our study, male gender, fall from height, and higher ISS at admission were derived as independent risk factors for HAIs. The predictive ability of ISS for HAIs was supported by findings of Sribnick et al.[9] Severe TBI and higher ISS are defined as risk factors for respiratory tract infections.[11] Male gender was found to be a risk factor for urinary tract infections in our study contrary to the findings described earlier.[20] Few studies also reported a significantly higher incidence of urinary tract infections in uncircumcised male children (20.1%) than in circumcised ones (2.4%). However, retrospectively we could not look into that aspect. Higher ISS was found as an independent predictive factor for CSF infection in pediatric TBI patients.[14] Younger age-group (0–2 years) was found more vulnerable for invasive device-related infection, probably owing to immunosuppression after TBI.[4] In our study, severe TBI, higher ISS and Marshall grade were significantly associated with poor outcomes as reported in the literature.[21,22] Also, the HAIs were found to be associated with an increased hospital stay, poor discharge GCS, and increased mortality. HAIs result in increased intensive care unit and hospital stay and more discharge to the rehabilitation center.[9,14] Our study represents HAIs and their impact on the outcome in pediatric TBI patients, which is not widely reported. Though, our study is a single-center retrospective study that can be considered as limitations of this analysis; however, this could be mitigated to some extent due to large sample (>400) and long duration data (7 years) of one of the largest level 1 trauma care hospital in the country.

CONCLUSION

Pediatric TBI patients are prone to develop HAIs. Multidrug-resistant A. baumannii was the most common microorganism isolated in nosocomial pediatric TBI patients in our study. Male gender, severe TBI, and higher ISS were the main risk factors identified for HAIs. Severe TBI, HAIs, higher ISS, and Marshall grade were found to be significantly associated with poor outcome in the present study.[23]
  23 in total

1.  Epidemiology of sepsis in patients with traumatic injury.

Authors:  Tiffany Medlin Osborn; J Kathleen Tracy; James R Dunne; Michael Pasquale; Lena M Napolitano
Journal:  Crit Care Med       Date:  2004-11       Impact factor: 7.598

2.  Hospital-acquired pneumonia among pediatric trauma patients treated at national trauma centers.

Authors:  Henry W Ortega; Gretchen Cutler; Jill Dreyfus; Andrew Flood; Anupam Kharbanda
Journal:  J Trauma Acute Care Surg       Date:  2015-06       Impact factor: 3.313

Review 3.  Immune suppression and isolated severe head injury: a significant clinical problem.

Authors:  D E Boddie; D G Currie; O Eremin; S D Heys
Journal:  Br J Neurosurg       Date:  2003-10       Impact factor: 1.596

4.  Sepsis in intensive care unit patients with traumatic brain injury: factors associated with higher mortality.

Authors:  Luis Carlos Maia Cardozo Júnior; Redson Ruy da Silva
Journal:  Rev Bras Ter Intensiva       Date:  2014 Apr-Jun

Review 5.  Pediatric Traumatic Brain Injury: Characteristic Features, Diagnosis, and Management.

Authors:  Takashi Araki; Hiroyuki Yokota; Akio Morita
Journal:  Neurol Med Chir (Tokyo)       Date:  2017-01-20       Impact factor: 1.742

6.  Risk factors for urinary tract infection in children with urinary urgency.

Authors:  Rhaiana Gondim; Roberta Azevedo; Ana Aparecida Nascimento Martinelli Braga; Maria Luiza Veiga; Ubirajara Barroso
Journal:  Int Braz J Urol       Date:  2018 Mar-Apr       Impact factor: 1.541

7.  Antimicrobial susceptibility pattern of Acinetobacter isolates from patients in Kenyatta National Hospital, Nairobi, Kenya.

Authors:  Victor Moses Musyoki; Moses Muia Masika; Winnie Mutai; Gitau Wilfred; Antony Kuria; Felista Muthini
Journal:  Pan Afr Med J       Date:  2019-06-26

8.  Epidemiologic analysis and control strategy of Klebsiella pneumoniae infection in intensive care units in a teaching hospital of People's Republic of China.

Authors:  Chunrui Wang; Zhe Yuan; Wenxiang Huang; Li Yan; Jun Tang; Cheng-Wei Liu
Journal:  Infect Drug Resist       Date:  2019-02-12       Impact factor: 4.003

9.  Antimicrobial susceptibility pattern of Staphylococcus aureus isolates from clinical specimens at Kenyatta National Hospital.

Authors:  Wilfred Gitau; Moses Masika; Moses Musyoki; Beatrice Museve; Titus Mutwiri
Journal:  BMC Res Notes       Date:  2018-04-03

10.  Modified Revised Trauma-Marshall score as a proposed tool in predicting the outcome of moderate and severe traumatic brain injury.

Authors:  Tjokorda Gde Bagus Mahadewa; Nyoman Golden; Anne Saputra; Christopher Ryalino
Journal:  Open Access Emerg Med       Date:  2018-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.